Enter to open, tab to navigate, enter to select
AbbVie Inc. and Stemcentrx, Inc. merger
| April 25, 2016 • Private Acquisition Agreements • $5.8 billion (approximate deal value taken from press release; subject to purchase price adjustment and additional earn-out payment). |
End of Document
© 2024 Thomson Reuters. No claim to original U.S. Government Works.